Slides: Novel strategies targeting residual risk: The promise of PCSK9 inhibiting therapies
Slides prepared and presented by prof Erik Stroes, MD - Academic Medical Center Amsterdam, The Netherlands, at the PACE-CME symposium held at ESC 2016 in Rome, Italy
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.